Safety and efficacy of combining pembrolizmumab and dose escalation/fraction de-escalation SRS for melanoma and NSCLC brain metastasis: Preliminary results from arm a of a prospective pilot trial

Autor:	David H. Lawson, Rafi Ahmed, Mohammad K. Khan, Lily Masoumy, Suresh S. Ramalingam, Alice O. Kamphorst, Tahseen H. Nasti, Ragini R. Kudchadkar, Taofeek K. Owonikoko, Melinda I Yushak
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty Lung Standard of care business.industry Melanoma medicine.medical_treatment Pilot trial medicine.disease Radiation therapy medicine.anatomical_structure Internal medicine medicine Dose escalation business De-escalation Brain metastasis
Zdroj:	Journal of Clinical Oncology. 36:e21542-e21542
ISSN:	1527-7755 0732-183X
Popis:	e21542Background: Brain metastases occur in 15–40% of patients (pts) with systemic cancers, such as lung and melanoma. The standard of care for brain metastases is radiation therapy. Methods to min...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::45c7240b357d46c67ef7490548be9534 https://doi.org/10.1200/jco.2018.36.15_suppl.e21542 Zobrazit plný text záznamu